The Mitsche lab uses mass spectrometry and stable isotope labeling to understand the progression of metabolic syndrome, in particular fatty liver and cardiovascular disease.
Our primary focus is understanding the link between alterations in fat composition disease. We aim to understand how alteration in function of enzymes involved in the biosynthesis and assembly of complex lipids and diet are related to poor health outcomes.
